Evidence
Pediatr Clin North Am. 2024 Apr;71(2):283-299. doi: 10.1016/j.pcl.2023.12.001. Epub 2024 Jan 5.
ABSTRACT
Persons with autism spectrum disorder (ASD) may have other psychiatric conditions that warrant treatment. Symptoms may not be easy to discern from rigidity or irritability that are sometimes considered to be constituent parts of ASD. Pathophysiology that involves hyperexcitable neurons and anomalous connectivity may provide justification for using psychopharmacologic agents, although nonmedical strategies may also be effective. Hyperactivity, irritability, and tantrums with or without aggression may be rational targets for psychopharmacological intervention. The best-studied drug class to date has been the second-generation antipsychotics targeting irritability.
PMID:38423721 | DOI:10.1016/j.pcl.2023.12.001
Add to Google Keep
Post to X
Share on Linkedin
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Psychopharmacology Management in Autism Spectrum Disorder
🌐 90 Days
VR Related Evidence Matrix
Evidence Blueprint
Psychopharmacology Management in Autism Spectrum Disorder
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychopharmacology Management in Autism Spectrum Disorder
🌐 365 Days
VR Related Evidence Matrix
